Pfizer execs talk Metsera obesity drug
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York…
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York…
Pfizer Inc. (NYSE:PFE) is one of the best high volume stocks to buy right now. On December 16, Bank of…
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term…
Source: Bloomberg, 4:33 www.bloomberg.com #Flights #Cancelled #Pfizer #Bid #Metsera
Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover…
Source: Bloomberg, 0:00 www.bloomberg.com #Pfizer #Bids #10B #Metsera #SCOTUS #Pauses #Full #SNAP #Pay
Source: Bloomberg, 0:00 www.bloomberg.com #Pfizer #Buy #Metsera #10B #SCOTUS #Pauses #SNAP #Order
Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk…
Contest has sparked a hot bidding war and a court battle. www.bloomberg.com #Novo #Locks #Horns #Pfizer #Obesity #Startup #Metsera
Novo Nordisk again increased its offer for Metsera as its takeover battle with Pfizer for the obesity startup escalates. CEO…